European Organisation for Research and Treatment of Cancer - EORTC: Head and Neck Neoplasms trials

The registry lists 10 Head and Neck Neoplasms studies with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 4Phase 3 3No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare StudyWithdrawnNCT06347185Not applicable
• Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By SurgeryTerminatedNCT00646659Phase 2
• BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsCompletedNCT00526149Phase 2
• Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or HypopharynxCompletedNCT00498953Phase 1/2
• NGR-TNF in Treating Patients With Advanced Solid TumorsCompletedNCT00098943Phase 1
• Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver MetastasesCompletedNCT00062348Phase 1
• Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerCompletedNCT00022594Phase 2
• Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck CancerTerminatedNCT00017277Phase 3
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00003888Phase 3
• High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck CancerCompletedNCT00002555Phase 3